Skip to content
Screener

AirSculpt Technologies, Inc. AIRS Total Liabilities & Equity

Total Liabilities & Equity at other companies

Eli Lilly logo
Eli LillyLLY
$142.28B+41.0%
AbbVie logo
AbbVieABBV
$136.46B+0.2%
Apyx Medical Corporation logo
Apyx Medical CorporationAPYX
$63.03M+4.8%
Establishment Labs logo
Establishment LabsESTA
$351.93M+6.8%
Bausch Health Companies logo
Bausch Health CompaniesBHC
$24.5B-7.3%

Other financials

Income statement

See full
Revenue$42.9M-2.5%
Gross profit$26.3M-1.8%
Operating income-$29.0K-104%
Net income-$1.1M-88.2%
EPS (diluted)-$0.02-100%

Balance sheet

See full
Cash & equivalents$18.8M+130%
Total debt$70.5M-17.4%
Total equity$104.8M+16.4%
Total assets$193.3M-2.6%

Cash flow

See full
Operating cash flow$5.3M+507%
CapEx$228.0K-14.0%
Free cash flow$5.2M+605%

Valuation

See full
Market cap$194M-50.2%
Enterprise value$245.64M-47.4%
P/S1.3×-1.1×

Profitability

See full
Gross margin59.7%+0.6pp
Operating margin-8.4%+14.7pp
Net margin-11.3%-25.1pp
FCF margin-0.1%

Returns & leverage

See full
Return on equity-21.6%-78.3pp
Debt / equity0.7×-0.3×
Current ratio0.8×+0.2×

Where this comes from

Reported directly by AirSculpt Technologies, Inc. in its filing.

Tagged under the XBRL concept us-gaap:LiabilitiesAndStockholdersEquity.

The source filing: AirSculpt Technologies, Inc.’s 10-Q, filed August 10, 2026.

Filed
Aug 10, 2026, 9:37 AM EDT
Fiscal quarter
Q2 FY2026
Calendar quarter
Q2 2026
Accession
0001870940-26-000038
Commitments and contingent liabilities (Note 9)
Stockholders' equity
Common stock, $0.001 par value; shares authorized - 450,000,000; shares issued and outstanding - 71,518,820 and 64,542,461, respectively7264
Additional paid-in capital149,300128,315
Accumulated other comprehensive loss(460)(96)
Accumulated deficit(44,080)(40,571)
Total stockholders' equity104,83287,712
Total liabilities and stockholders' equity$193,281$187,304

Item 1. Financial Statements

FAQ

What is AirSculpt Technologies, Inc.'s total liabilities & equity?
AirSculpt Technologies, Inc. (AIRS) reported total liabilities & equity of $193.28M in Q2 2026.
How has AirSculpt Technologies, Inc.'s total liabilities & equity changed year-over-year?
AirSculpt Technologies, Inc.'s total liabilities & equity decreased by 2.6% year-over-year, from $198.37M to $193.28M.
What is the long-term trend for AirSculpt Technologies, Inc.'s total liabilities & equity?
Over 5 years (2020 to 2025), AirSculpt Technologies, Inc.'s total liabilities & equity has grown at a 0.8% compound annual growth rate (CAGR), from $179.61M to $187.3M.
What does total liabilities & equity mean?
Total assets = total liabilities + total equity. This must always balance — a fundamental accounting identity.

Ask your AI about AirSculpt Technologies, Inc.'s total liabilities & equity.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude